Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
This research-grade glucagon-like peptide-1 (GLP-1) lyophilized vial delivers a total strength of 10mg in a clean, stable format designed for controlled laboratory work
Customs and shipping fees are not included
Regular follow-up appointments are essential for monitoring weight loss progress, adjusting doses, managing side effects, and screening for complications
The structured dosing recommendations contribute to a more efficient and targeted treatment plan, enhancing the overall effectiveness of semaglutide in supporting weight loss goals
Weight loss results vary significantly by specific medication and dose: Semaglutide 2.4 mg (Wegovy): Clinical trials (STEP program) showed average weight reductions of 1517% at 68 weeks Tirzepatide (Zepbound): SURMOUNT trials demonstrated weight reductions of 1522% at 72 weeks, with results varying between populations with and without diabetes Liraglutide 3 mg (Saxenda): Typically produces 510% weight loss over 56 weeks The rate of weight loss is not linear
